Approaches to limiting emergence of antimicrobial resistance in bacteria in human populations.

Infectious diseases continue to be major threats to human health around the world. Within the past few years, several divergent groups of organisms have emerged as significant causes of morbidity and mortality. Included among these are bacteria that are refractory to therapy because of the development of resistance to multiple antimicrobial agents. Multidrug resistance in strains of Mycobacterium tuberculosis, Streptococcus pneumoniae, Shigella dysenteriae, Salmonella typhi, and Enterococcus faecium has been reported. Surveillance of resistant microorganisms in the United States and abroad is fragmentary and targets relatively few organisms. Surveillance is further hampered by the fact that detection of some novel resistance mechanisms is difficult by means of current laboratory methods. Both clinicians and public health officials are likely to continue to face a variety of challenges regarding surveillance, treatment, prevention, and control of drug-resistant infections.

[1]  J. V. Loon,et al.  The End of Antibiotics , 1997 .

[2]  Morris Jg.  Vibrio cholerae O139 Bengal: emergence of a new epidemic strain of cholera. , 1995 .

[3]  J. Hughes,et al.  Trends in antimicrobial drug prescribing among office-based physicians in the United States. , 1995, JAMA.

[4]  J. P. Davis,et al.  A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. , 1994, The New England journal of medicine.

[5]  F. Tenover,et al.  Emergence of drug-resistant pneumococcal infections in the United States. , 1994, JAMA.

[6]  A. Tomasz,et al.  Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. , 1994, The New England journal of medicine.

[7]  J M Hughes,et al.  Infectious disease surveillance: a crumbling foundation. , 1994, Science.

[8]  L. Sutton,et al.  Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases , 1994, Journal of clinical microbiology.

[9]  N. Bean,et al.  Epidemic cholera in Ecuador: multidrug–resistance and transmission by water and seafood , 1994, Epidemiology and Infection.

[10]  M. Ferraro,et al.  Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test , 1994, Journal of clinical microbiology.

[11]  J. Childs,et al.  Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. , 1993, Science.

[12]  J. Tokars,et al.  Ability of Clinical Laboratories To Detect Antimicrobial Agent-Resistant Enterococci , 1993, Journal of clinical microbiology.

[13]  R. Gaynes,et al.  An overview of nosocomial infections, including the role of the microbiology laboratory , 1993, Clinical Microbiology Reviews.

[14]  R. Clárk,et al.  Comparison of susceptibility test methods to detect penicillin-resistant Streptococcus pneumoniae. , 1993, Diagnostic microbiology and infectious disease.

[15]  K. Singh,et al.  Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  J. Wells,et al.  Cholera in Piura, Peru: a modern urban epidemic. , 1992, The Journal of infectious diseases.

[17]  W J Martone,et al.  Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. , 1992, Infection control and hospital epidemiology.

[18]  H. Neu,et al.  The Crisis in Antibiotic Resistance , 1992, Science.

[19]  A. Bolmström,et al.  Evaluation of the E-Test for susceptibility testing of pneumococci. , 1992, Diagnostic microbiology and infectious disease.

[20]  J. T. Crawford,et al.  An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. , 1992, The New England journal of medicine.

[21]  B. Murray.  New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. , 1991, The Journal of infectious diseases.

[22]  B. Plikaytis,et al.  Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. , 1991, The Journal of infectious diseases.

[23]  K. Holmes,et al.  National surveillance of antimicrobial resistance in Neisseria gonorrhoeae , 1990, JAMA.

[24]  D. Sahm,et al.  In vitro detection of enterococcal vancomycin resistance , 1990, Antimicrobial Agents and Chemotherapy.

[25]  J. Lederberg.  Medical science, infectious disease, and the unity of humankind. , 1988, JAMA.

[26]  P. MANSON-BAHR,et al.  Natural History of Infectious Disease , 1953, Nature.

[27]  The Plague in India , 1898, The Hospital.

[28]  Dengue type 3 infection. Nicaragua and Panama, October-November 1994. , 1995, Releve epidemiologique hebdomadaire.

[29]  J. Wells,et al.  A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. , 1994, JAMA.

[30]  J J Rahal,et al.  Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. , 1994, The New England journal of medicine.

[31]  Nosocomial enterococci resistant to vancomycin--United States, 1989-1993. , 1993, MMWR. Morbidity and mortality weekly report.

[32]  C. Infante-Rivard,et al.  Otitis media in children: frequency, risk factors, and research avenues. , 1993, Epidemiologic reviews.

[33]  S. Schappert.  Office visits for otitis media: United States, 1975-90. , 1992, Advance data.

[34]  Joshua Lederberg,et al.  Emerging Infections: Microbial Threats to Health in the United States , 1992 .